Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery : An International Prospective Cohort Study
(2024) In Aesthetic Surgery Journal 44(12). p.1317-1329- Abstract
Background: The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for the BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive as important. Objectives: The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q. Methods: Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods... (More)
Background: The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for the BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive as important. Objectives: The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q. Methods: Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods were used to estimate MID: 0.2 standard deviations of mean baseline scores and the mean standardized response change of BODY-Q scores from baseline to 3 years postoperatively. Results: A total of 12,554 assessments from 3237 participants (mean age 42.5 ± 9.3 years; BMI 28.9 ± 4.9 kg/m2) were included. Baseline MID scores ranged from 1 to 5 on the health-related quality of life (HRQL) scales and 3 to 6 on the appearance scales. The estimated MID scores from baseline to 3-year follow-up ranged from 4 to 5 for HRQL and from 4 to 8 on the appearance scales. Conclusions: The BODY-Q MID estimates from before BCS to 3 years postoperatively ranged from 4 to 8 and are recommended for interpretation of patients’ BODY-Q scores, evaluation of treatment effects of different BCS procedures, and calculation of sample size for future studies.
(Less)
- author
- organization
- publishing date
- 2024-12-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Aesthetic Surgery Journal
- volume
- 44
- issue
- 12
- pages
- 13 pages
- publisher
- Oxford University Press
- external identifiers
-
- pmid:39041862
- scopus:85209699970
- ISSN
- 1090-820X
- DOI
- 10.1093/asj/sjae162
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © The Author(s) 2024.
- id
- 385fdd5e-acec-40ac-ac08-17c590ad050c
- date added to LUP
- 2025-01-09 08:59:40
- date last changed
- 2025-07-11 13:42:52
@article{385fdd5e-acec-40ac-ac08-17c590ad050c,
abstract = {{<p>Background: The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for the BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive as important. Objectives: The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q. Methods: Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods were used to estimate MID: 0.2 standard deviations of mean baseline scores and the mean standardized response change of BODY-Q scores from baseline to 3 years postoperatively. Results: A total of 12,554 assessments from 3237 participants (mean age 42.5 ± 9.3 years; BMI 28.9 ± 4.9 kg/m<sup>2</sup>) were included. Baseline MID scores ranged from 1 to 5 on the health-related quality of life (HRQL) scales and 3 to 6 on the appearance scales. The estimated MID scores from baseline to 3-year follow-up ranged from 4 to 5 for HRQL and from 4 to 8 on the appearance scales. Conclusions: The BODY-Q MID estimates from before BCS to 3 years postoperatively ranged from 4 to 8 and are recommended for interpretation of patients’ BODY-Q scores, evaluation of treatment effects of different BCS procedures, and calculation of sample size for future studies.</p>}},
author = {{Dalaei, Farima and Dijkhorst, Phillip J. and Möller, Sören and Klassen, Anne F. and de Vries, Claire E.E. and Poulsen, Lotte and Kaur, Manraj N. and Thomsen, Jørn Bo and Hoogbergen, Maarten and Voineskos, Sophocles H. and Repo, Jussi P. and Opyrchal, Jakub and Paul, Marek Adam and Busch, Kay Hendrik and Cogliandro, Annalisa and Rose, Michael and Cano, Stefan J. and Pusic, Andrea L. and Sørensen, Jens A.}},
issn = {{1090-820X}},
language = {{eng}},
month = {{12}},
number = {{12}},
pages = {{1317--1329}},
publisher = {{Oxford University Press}},
series = {{Aesthetic Surgery Journal}},
title = {{Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery : An International Prospective Cohort Study}},
url = {{http://dx.doi.org/10.1093/asj/sjae162}},
doi = {{10.1093/asj/sjae162}},
volume = {{44}},
year = {{2024}},
}